BioSig Technologies, Inc. (BSGM)
NASDAQ: BSGM · Real-Time Price · USD
4.290
-0.330 (-7.14%)
At close: Aug 1, 2025, 4:00 PM
4.440
+0.150 (3.50%)
After-hours: Aug 1, 2025, 7:36 PM EDT
Accolade Revenue
BioSig Technologies had revenue of $26.00K in the twelve months ending March 31, 2025, down -3.70% year-over-year. In the year 2024, BioSig Technologies had annual revenue of $40.00K with 122.22% growth.
Revenue (ttm)
$26.00K
Revenue Growth
-3.70%
P/S Ratio
5,080.84
Revenue / Employee
$5,200
Employees
5
Market Cap
132.10M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 40.00K | 22.00K | 122.22% |
Dec 31, 2023 | 18.00K | -268.00K | -93.71% |
Dec 31, 2022 | 286.00K | -155.00K | -35.15% |
Dec 31, 2021 | 441.00K | - | - |
Dec 31, 2020 | - | - | - |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
BSGM News
- 18 days ago - CORRECTION: BioSig & Streamex Clarify and Correct Details of Russell Starr's Appointment and Biography - Business Wire
- 19 days ago - BSGM Engages CXG to Acquire FINRA/SEC-Registered Broker-Dealer to Expand Publicly Traded RWA Tokenization Operations - Business Wire
- 19 days ago - CORRECTING and REPLACING BioSig & Streamex Appoint Defi Expert and Visionary, Russell Starr as Strategic Advisor - Business Wire
- 22 days ago - BioSig & Streamex Appoint Defi Expert and Visionary, Russell Starr as Strategic Advisor - Business Wire
- 7 weeks ago - BioSig & Streamex Appoint Parcl Co-Founders Trevor Bacon and Kellan Grenier as Strategic Advisors - GlobeNewsWire
- 2 months ago - BioSig & Streamex Appoint Co-Founder of the Osisko Group & Mining Visionary, Sean Roosen as Strategic Advisor - GlobeNewsWire
- 2 months ago - BIOSIG TECHNOLOGIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of BioSig Technologies, Inc. - BSGM - Business Wire
- 2 months ago - CORRECTION: Streamex and BioSig Appoint Former OppenheimerFunds and Wafra Inc Executive, Mitch Williams, CFA, as Chief Investment Officer (CIO) - GlobeNewsWire